Contracts Finder · Award
Oncotype DX Breast recurrence score test
A public procurement published by Leeds Teaching Hospital NHS Trust via Contracts Finder.
- £191.7k
- Award value
- £191.7k
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Award
- Stage
Overview
Breast Cancer Recurrence Score Test contract ref PTH-22-21-11621 Contract extension taken 1st July 2025
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 33696200 — Blood-testing reagents
- Currency
- GBP
- Total award value
- £191,700
- Tender value
- £191,700
- First published
- 24 Oct 2025
- Last updated
- 24 Oct 2025
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Exact Sciences UK, Ltd. | 07484560 | 19 Oct 2025 | active | £191.7k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
FAQs about this procurement
Who is the buyer for "Oncotype DX Breast recurrence score test"?
Oncotype DX Breast recurrence score test is a UK public-sector procurement published by Leeds Teaching Hospital NHS Trust via Contracts Finder.
Has "Oncotype DX Breast recurrence score test" been awarded?
Yes — 1 award is recorded, with a reported total value of £191,700. The current lifecycle stage is "Award".
Which suppliers are involved in "Oncotype DX Breast recurrence score test"?
1 supplier is linked: Exact Sciences UK, Ltd..
What is "Oncotype DX Breast recurrence score test" worth?
The reported award value is £191,700.
When was "Oncotype DX Breast recurrence score test" published?
It was first published on 24 Oct 2025 and last updated on 24 Oct 2025, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable